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ABSTRACT
Human mitochondrial methionine transfer RNA
ðhmtRNA
Met
CAUÞ has a unique post-transcriptional mod-
ification, 5-formylcytidine, at the wobble position-34
(f
5C34). The role of this modification in hmtRNA
Met
CAU
for the decoding of AUA, as well as AUG, in both
the peptidyl- and aminoacyl-sites of the ribosome
in either chain initiation or chain elongation is still
unknown. We report the first synthesis and analyses
of the tRNA’s anticodon stem and loop domain con-
taining the 5-formylcytidine modification. The mod-
ification contributes to the tRNA’s anticodon
domain structure, thermodynamic properties and
its ability to bind codons AUA and AUG in transla-
tional initiation and elongation.
INTRODUCTION
Mitochondria generate over 90% of the energy used by
mammalian cells through oxidative phosphorylation.
Thirteen proteins, components of the electron transfer
chain and the ATP synthase, are the products of mito-
chondrial DNA. The synthesis of these proteins is carried
out by a speciﬁc protein synthesizing machinery within
this organelle. During the almost-three decades since the
sequencing of the human mitochondrial genome (1), the
mitochondrial genetic code has been found to diﬀer sig-
niﬁcantly from the universal code. The human mitochon-
drial gene for the one methionine speciﬁc tRNA
(hmtRNA
Met
CAU, where CAU is the anticodon) plays a
unique role since it must provide the tRNA used for
both the initiation of protein synthesis and the elongation
of the protein chain by responding to the codon AUA,
normally an isoleucine codon in the cytoplasm, as well
as the universal methionine code, AUG. This is highly
unusual since all cytoplasmic protein biosynthetic systems
employ two diﬀerent tRNA
Met species, one for initiation
and one for elongation, and both respond to the single
methionine codon, AUG. Maternally inherited mutations
in the gene of this tRNA, including an A37 to G37 muta-
tion adjacent to the anticodon nucleosides that read the
two codons (Figure 1), are responsible for some devastat-
ing diseases (2–5). Moreover, the hmtRNA
Met
CAU has a
unique modiﬁcation, 5-formylcytidine (Figure 1), at the
wobble position-34 (f
5C34) seen only in one other tRNA,
a bovine liver, cytoplasmic tRNA
Leu with a f
5C34 further
modiﬁed with a 20O-methyl (6). Nothing, however, is
known about the decoding characteristics of
tRNA
Leu 5
f CmAA. Since its discovery in bovine and nematode
mitochondrial tRNA
Met in 1994 (7,8), f
5C34 also has been
found in the mitochondrial tRNA
Met of squids, frogs,
chickens, rats and fruit ﬂies (9–11). The contribution of
the f
5C34 modiﬁcation to the structure of the
hmtRNA
Met
CAU, its role in the decoding of AUG and
AUA and its possible participation in either chain initia-
tion or chain elongation by this unique tRNA
Met is still
unknown.
We speculate that mitochondria have a unique mecha-
nism to partition this single hmtRNA
Met
CAU species between
initiation and elongation. While a tRNA
Met
CAU unmodiﬁed
at the wobble position-34 can read AUG, we hypothesize
that the 5-formyl modiﬁcation allows one tRNA
Met to
expand codon reading to include recognition of the
AUA codon in mitochondrial mRNAs. Toward proving
the hypothesis that this wobble modiﬁcation aﬀords the
single tRNA
Met the ability to decode AUG and AUA,
we are reporting the ﬁrst synthesis of a 5-formylcytidine-
modiﬁed RNA and the initial structural and biological
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tRNA
Met
CAU had been shown to translate AUG and AUA
in an Escherichia coli translational system in vitro, where
AUG coded for methionine and AUA for isoleucine (12).
However, site-speciﬁc binding was not investigated.
Here we compare the codon binding aﬃnities of the
f
5C34-modiﬁed anticodon stem and loop of human mito-
chondrial tRNA
Met (hmtASL
Met-f
5C34) with that of the
unmodiﬁed ASL. Our results for both AUA and AUG
codons at both the A and P-site of E. coli ribosomes
increase our understanding of the modiﬁcation’s contribu-
tions to decoding and are consistent with previous results
from the translation of poly(AUA) by bovine mtRNA
Met
CAU
on E. coli ribosomes (12).
MATERIALS AND METHODS
Experimental procedures and analytical dataforthe
synthesis of thef
5Cphosphoramidite (9)
All reagents used in the following experiments are of the
highest purity and dryness possible. Before use, glassware
was thoroughly cleaned and dried (oven at 1108C for
30min). NMR analysis of intermediates was conducted
in the appropriate deuterated solvent (referenced accord-
ingly for CDCl3:
1H 7.24p.p.m.,
13C 77.23p.p.m.; and
CD3CN:
1H 1.94p.p.m.) using a Bruker Avance Ultra-
shield 300MHZ spectrometer. Phosphorus,
31P, NMR
experiments were referenced according to an external
H3PO4 standard (0.00p.p.m.). Mass-spec analysis of the
samples was performed on a Micromass LCT ESI-TOF or
an Agilent LC-TOF. Analytes were dissolved in acetoni-
trile and ﬂown against a Leucin Enkephalin lock mass
standard. Chemical and physical properties of the inter-
mediates were those of the expected compounds (Supple-
mentary Data).
20,30-O-isopropylidenecytidine (2). To a suspension of
cytidine (1, Figure 2, 1g, 4.1mmol) in 50ml of acetone
was added 2,2-dimethoxypropane (6ml, 5.1g, 49mmol).
HClO4 was then added dropwise until the solution turned
clear. The reaction mixture was stirred at room tempera-
ture for 12h, after which it was neutralized by addition of
Ca(OH)2, ﬁltered and evaporated. Puriﬁcation by silica gel
chromatography using CHCl3:MeOH (80:20) with 2%
TEA, aﬀorded 966mg of 2 as a white foam (83% yield).
The analytical data obtained matched known literature
data for 2 (13).
5-(Hydroxymethyl)- 20,3 0-O-isopropylidenecytidine (3).
To a solution of 2 (Figure 2, 1g, 3.5mmol) in 15ml of
0.5M KOH was added paraformaldehyde (1.05g,
35mmol). The reaction was stirred at 558C for 36h,
after which it was cooled to room temperature and neu-
tralized with 6MHCl. The solution was ﬁltered and eva-
porated. The oily residue was dissolved in MeOH: DCM
(40:60), ﬁltered and evaporated again. Puriﬁcation by
silica gel chromatography using MeOH:DCM (gradient
3:97, 8:92, 12:88) with 2% TEA, aﬀorded 416mg of 5-
(hydroxymethyl)-20,30-O-isopropylidenecytidine (3)a sa
white foam (38% yield, 60% yield based on 357mg of
recovered starting material 20,30-O-isopropylidenecytidine
(2).
5-Formyl-20,3-O-isopropylidenecytidine (4). To 3
(Figure 2, 100mg, 0.32mmol) in 3ml dioxane was added
500mg ruthenium dioxide hydrate (ﬁve weight equiva-
lents). The reaction mixture was reﬂuxed for 12h
and ﬁltered. Puriﬁcation by silica gel chromatography
MeOH:DCM (5:95) with 2% TEA, aﬀorded 81mg of
the 5-formyl-20,30-O-isopropylidenecytidine (4) as a white
solid (82% yield).
5-Formylcytidine (5). The acetonide, 5-formyl-20,30-O-
isopropylidenecytidine (4, Figure 2, 500mg, 1.61mmol)
was suspended in 1M HCl (15ml) at room temperature.
The reaction progress was monitored by TLC. Upon dis-
appearance of the starting material, the solution was neu-
tralized with TEA. Water was subsequently evaporated.
Recrystalization from MeOH aﬀorded 414mg of f
5C( 5)
as a white solid (95% yield).
N
4-[(Diisobutylamino)methylidene]-30,50-O-(1,1,3,3-tetra-
isopropyl-1,3-disiloxanediyl)-5-formylcytidine (6). 5-For-
mylcytidine (5, Figure 2, 0.47g, 1.72mmol) was
dissolved in a mixture of 20ml of pyridine and 2ml of
DMF. The solution was cooled to 08C and TIPDSCl2
(0.59g, 1.89mmol) in 2ml of pyridine was added dropwise
over a period of 1h. The reaction was allowed to gradually
warm to room temperature overnight. The following
morning the reaction was quenched with 5ml of MeOH
and evaporated to dryness. The resulting paste was coe-
vaporated twice with 20ml of toluene and the crude mate-
rial was puriﬁed by ﬂash chromatography on 30ml of
silica gel using a gradient of MeOH in DCM (3–4%).
Product fractions were pooled and evaporated to aﬀord
the TIPDS protected intermediate (0.88g, 100%) as light
yellow oil that is contaminated with residual pyridinium
salts. The above compound was used as is without further
puriﬁcation to remove the residual pyridinium salts.
TIPDS protected f
5C( 5) (0.88g, 1.72mmol) was dissolved
Figure 1. Human mitochondrial tRNA
Met
CAU. The sequence and second-
ary structure of hmtRNA
Met
CAU are shown with the heptadecamer, antic-
odon stem and loop domain in bold. Nucleosides 27 and 50 are
modiﬁed to pseudouridine, . The wobble position-34 modiﬁcation is
5-formylcytidine, f
5C34.
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acetal (14) (0.70g, 3.44mmol) was added. The reaction
was stirred for 16h and evaporated under high vacuum.
The resulting loose oil was coevaporated twice with 20ml
of toluene and the crude material was puriﬁed by ﬂash
chromatography on 30ml of silica gel using a gradient
of MeOH in DCM (1–2%). Product fractions were
pooled and evaporated to aﬀord 0.80g of 6 as light
yellow oil in 71% overall yield from f
5C( 5).
20-O-[Bis(2-acetoxyethoxy)methyl]-N
4-[(diisobuty-
lamino) methylidene]-5-formylcytidine (7). A mixture of
6 (Figure 2, 0.80g, 1.23mmol), pyridinium para-toluene-
sulfonate (0.31g, 1.23mmol), and Tris(2-acetoxyethoxy)-
methyl orthoformate (1.98g, 6.15mmol) was dissolved in
5ml of DCM and stirred at room temperature. After
2 days, TBDMS-pentanedione (0.53g, 2.46mmol) was
added and the reaction was stirred at ambient tempera-
ture. After stirring for an additional day, the reaction was
quenched with 1ml of TEMED. The crude material was
separated from excess reagents by ﬂash chromatography
on 50 ml silica gel using a gradient of 25% ethyl acetate in
hexanes with 0.1% TEMED to 50% ethyl acetate in
hexanes with 0.1% TEMED. This material was concen-
trated to near dryness and taken directly onto the desilyla-
tion reaction.
A freshly made solution of TEMED (0.71g, 6.15mmol)
in 10ml of acetonitrile at 08C was added 48% HF
(0.15ml, 4.30mmol). This solution was allowed to stir
for 5min and added to the foregoing material from
above at room temperature. The reaction was stirred for
2h and concentrated to dryness. The crude material was
puriﬁed by ﬂash chromatography on 50ml silica gel using
a gradient of 20% heaxanes in ethyl acetate with 0.1%
TEMED to 1% methanol in ethyl acetate with 0.1%
TEMED. Product fractions were pooled and evaporated
to leave the 20-O-protected compound [7] as a light yellow
oil (0.41g) in 53% yield from the nucleobase protected
compound 6.
50-O-[Benzyhydryloxy-bis(trimethylsilyloxy)silyl]-20-O-
[bis(2-acetoxyethoxy)-methyl]-N
4-[(diisobutyl-amino)-
methylidene]-5-formylcytidine (8). Diisopropylamine
(0.07g, 0.65mmol) was added to a solution of the 20-O-
and N
4-protected nucleoside, 7 (Figure 2, 0.41g,
0.65mmol) in 7ml of DCM and the solution was cooled
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Figure 2. Synthesis of the 5-formylcytidine phosphoramidite. The starting compound cytidine is numbered compound 1, intermediates are numbered
2–8 and the protected f
5C phosphoramidite is compound 9. The synthetic transformations are: (a) acetone, dimethoxypropane, cat HClO4 (83%);
(b) paraformaldehyde, 0.5M KOH, 558C (38%, 60% brsm); (c) RuO2 xH2O, dioxane, reﬂux (82%); (d) 1M HCl (95%); (e) TIPDSCl2, Pyr, DMF;
(f) DBF-CH(OMe)2, DMF (71% over 2 steps); (g) ACE-orthoester, PPTS, TBDMS-pentanedione, DCM; (h) HF-TEMED, CH3CN (53% over
2 steps); (i) BZH-Cl, DIA, DCM (84%); (j) P(OMe)(DIA)2, DIA, S-Et Tetrazole, DCM (93%).
6550 Nucleic Acids Research, 2008, Vol. 36, No. 20to 08C. In a separate ﬂask BZHCl (0.34g, 0.81mmol) was
diluted in 5ml of DCM. Diisopropylamine (0.10g,
0.98mmol) was added to the silylating solution and the
solution was allowed to stir for 2min before being added
dropwise to the nucleoside solution. The addition was
completed within 30min and the reaction was allowed to
stir for 3h and the reaction was quenched with 1ml of
MeOH and evaporated to dryness. The crude material
was puriﬁed by ﬂash chromatography on 30ml silica gel
using a gradient of 10% acetone in hexanes containing
0.1% (v/v) TEA to 20% acetone in hexanes containing
0.1% (v/v) TEA. Product fractions were pooled and eva-
porated to aﬀord the 50-O- protected compound 8 as a
colorless oil. The yield was 0.56g (84%).
50-O-[Benzyhydryloxy-bis(trimethylsilyloxy)silyl]-20-O-
[bis(2-acetoxyethoxy)-methyl]-N
4-[(diisobutyl-amino)
methylidene]-5-formylcytidine-30-(methyl-N,N-diisopro-
pyl) phosphoramidite (9). Bis(diisopropyl-amino) meth-
oxy phosphine (0.21g, 0.82mmol) was dissolved in 3ml
of DCM and a 0.5-M solution of 5-ethylthio-1-H-tetrazole
in anhydrous acetonitrile (0.08ml, 0.55mmol) was added.
Diisopropylamine (0.06g, 0.55mmol) was then added and
the phosphine solution was allowed to stir for 5min at
ambient temperature. In a separate ﬂask, the 20-O-, 50-O-
and N
4-protected f
5C, compound 8 (Figure 2, 0.56g,
0.55mmol) and diisopropylamine (0.06g, 0.55mmol)
were dissolved in 5ml of DCM. The activated phosphine
solution was added into the nucleoside solution and the
reaction was stirred at room temperature. After 16h the
reaction was quenched with 2ml of absolute ethanol and
concentrated to dryness. The resulting white paste was
puriﬁed by ﬂash chromatography on 30ml of silica gel
using a mixture of DCM in hexanes [5:95 (v/v)] contain-
ing 2% (v/v) TEA followed by acetone in hexanes [1:9 (v/
v)] to 2:8 (v/v) containing 0.5% (v/v) TEA. Product frac-
tions were pooled and evaporated to aﬀord the protected
f
5C phosphoramidite 9 (Figure 2), as a colorless oil.
Polyribonucleotide synthesis of5’-CGGGCC-f
5C-AUA
CCCCCGA-3’
The above sequence was synthesized on a 1-mmol scale
using a ABI 394 DNA synthesizer using previously pub-
lished procedures (15,16). The f
5C phosphoramidite
(9, 0.067M in anhydrous acetonitrile) was coupled to
the growing polyribonucleotide chain for 3.5min using
5-ethylthio-1H-tetrazole (0.5M in anhydrous acetonitrile)
as the activator. Once the synthesis of the polyribonucleo-
tide chain was completed, the phosphate protecting
groups were removed from the immobilized polyribonu-
cleotide by treatment with disodium 2-carbamoyl-2-cya-
noethylene-1,1-dithiolate trihydrate in DMF for 10
minutes. The support was washed excessively with water
for 5min and then ﬂushed with Argon gas for 5min to dry
the support. The support was then transferred to a 2-ml
Eppendorf tube and the polyribonucleotide was cleaved
from the support and the exocyclic amine protecting
groups were removed with 1:3 (v/v) tert-butylamine:water
for 6h at 608C. The sample was cooled to room tempera-
ture, ﬁltered and lyophilized to obtain the crude
polyribonucleotide. The hmASL
Met
CAU -27;f
5C34 was
deprotected with acetate/TEMED according to standard
Dharmacon protocols, puriﬁed by ion exchange HPLC
(17), and dialyzed extensively against H2O. The
hmASL
Met
CAU-27 was synthesized and deprotected under
standard conditions (18).
Confirmation of nucleoside composition by nucleoside
HPLC and NMR ofthe hmASL
Met
CAU constructs
Incorporation of f
5C modiﬁcation within the hmASL
Met
was conﬁrmed by NMR, including the two-dimensional
NOESY (Figures 3 and 4). The nucleoside composition
of the hmASL
Met products was conﬁrmed by enzymatic
hydrolysis of the RNA to its constituent nucleosides (17)
and then subjected to HPLC monitored by diode array
UV spectrometry, the peaks identiﬁed, integrated and
quantiﬁed (19) (Figure 4).
Analysisof thermodynamic stability, circular
dichroismand molecular dynamics simulations
The ASL samples were dissolved to obtain a concentration
of  4mM in 20mM Na–K phosphate buﬀer (pH 6.8).
UV-monitored, thermal denaturations and renaturations
were replicated ﬁve times and monitored by measuring
UV absorbance (260nm) using a Cary 3 spectrophotom-
eter as published (20,21). The data points were averaged
over 20s and collected four times a minute with a tem-
perature change of 0.58C/min from 4 to 908C. The data
were analyzed (22), and the thermodynamic parameters
were determined (Origin software, Microcal, Inc.)
(Figure 5A). CD spectral ellipticity data were collected
using a Jasco 600 spectropolarimeter and an interfaced
computer (Jasco, Inc.). hmASL
Met
CAU-27 or the
hmASL
Met
CAU- 27;f
5C34 (0.2 A260/ml, 20mM Na–K phos-
phate buﬀer, pH 6.8) was placed in a temperature-
regulated, 1-cm path-length quartz cell. Each sample was
scanned 10 times at 258C. The ﬁnal data are an average of
the 10 scans (Figure 5B). The molecular dynamics simula-
tion (MDS) were performed by following standard pub-
lished protocol (23) with the exception of using a
truncated octahedral TIP3P water box (24).
Ribosomal binding assay
The 27-mer mRNA oligos used in codon binding assays
were designed from that of T4 gp32 mRNA (25) and pur-
chased (Dharmacon RNA Technologies). They were
chemically deprotected and HPLC-puriﬁed in our lab.
Each mRNA sequence was entered into the program
RNA Structure 4.2 (26) and was found to have a low
probability of folding into any stable conformation. The
mRNA sequences are as follows (mitochondrial methio-
nine codons AUA and AUG are in bold):
(i) 50-GGCAAGGAGGUAAAAAUAGUAGCACG
U-30;
(ii) 50-GGCAAGGAGGUAAAAAUGGUAGCACGU-
30;
(iii) 50-GGCAAGGAGGUAAAAGUAAUAGCACG
U-30;
Nucleic Acids Research, 2008, Vol. 36, No. 20 6551Figure 4. HPLC nucleoside composition and NMR analyses of hmASL
Met
CAU and f
5C. (A) The upper section of the ﬁgure depicts the HPLC separation
of standard ribonucleosides where C, G and A (solid line) had been injected together, and U, G and f
5C (dotted line) had been injected in a separate
control experiment. The lower section depicts the chromatography of nucleoside composing the hmASL
Met
CAU to include , as well as f
5C. (B) The
NOESY connectivities between imino protons at 500MHz in a 2D
1H NOESY NMR spectrum (mix=250ms) of hmASL
Met
CAU (90%
1H2O+10%
2H2O; 20mM PO4
3–, 50mM NaCl, pH 6.2; 28C) with water suppression using the WATERGATE sequence. (C) 1D
1H NMR spectra of (a) cytidine
(1) and (b) 5-formylcytidine (5) (500MHz; 100%
2H2O; 20mM PO4
3–,5 0 m MN a
+,5 0 m MK
+; pH=6.2; 258C) using the presaturation NMR
sequence to suppress the water peak. The spectral regions and peaks corresponding to the various proton types in the molecules are labeled.
Figure 3. NMR spectra of the hmASL
Met
CAU. (A) One-dimensional 1H-NMR spectrum (in H2O) of hmASL
Met
CAU-27;f
5C34 (top) is compared to that of
the unmodiﬁed hmASL
Met
CAU-27 (bottom). The formyl proton’s chemical shift in the RNA is almost identical to that of the mononucleoside f
5C.
 Denotes impurities. (B) Superimposed
1H-
13C HMQC spectra of cytidine (blue) and 5-formylcytidine (red).
6552 Nucleic Acids Research, 2008, Vol. 36, No. 20(iv) 50-GGCAAGGAGGUAAAAGUAAUGGCACG
U-30.
The 70S ribosomes were prepared from E. coli MRE600
(27). The ASLs were 50-end
32P-labeled using [W-
32P] ATP
(MP Biomedicals). Unlabeled ASLs (5mM) were mixed
with 10000 CPM of 50-end
32P-labeled ASL. The assay
was performed in ribosomal binding buﬀer (50mM
HEPES, pH 7.0; 30mM KCl; 70mM NH4Cl; 1mM
DTT; 100mM EDTA; 20mM MgCl2). The ribosomes,
activated at 428C for 10min and then slowly cooled to
378C, were then programmed with 2.5mM mRNA for
15min at 378C. The ribosomal site not in observation
was saturated with ASL
Val3
UAC (unmodiﬁed) for 15min at
378C. P-site binding was performed prior to A-site bind-
ing. ASL
Val3
UAC binds to the Val codon GUA; see underlined
codons of the mRNA sequences above. Binding of
ASL
Met
CAU in either A- or P-site was allowed to proceed
for 30min at 378C. The reaction mixtures (20ml each)
were then placed on ice for 20min and ﬁltered through
nitrocellulose in a modiﬁed Whatman Schleicher and
Schuell (Brentford, UK) 96-well ﬁltration apparatus
(28). Prior to ﬁltration of experimental samples, the nitro-
cellulose ﬁlter was equilibrated in binding buﬀer at 48C for
at least 20min and each well of the ﬁltration apparatus
was washed with 100ml of cold binding buﬀer. Cold bind-
ing buﬀer (100ml) was added to each sample, and the
entire 120-ml volume was quickly ﬁltered. Each well was
then washed twice with 100ml of cold binding buﬀer. The
nitrocellulose was dried out on ‘kim’ wipes, and the radio-
activity was measured using a phosphorimager (Molecular
Dynamics, GE Healthcare). Data were measured for
radioactive intensity using ImageQuant (Amersham).
Nonspeciﬁc binding was determined by the binding of
ASLs to ribosomes without mRNA and subtracted from
the experimental data. The ﬁnal data are a result of at least
three separate experiments, each done with samples in
triplicate, i.e. minimally nine determinations for each
binding (Figure 6).
Analysisof thef
5CpKa
UV spectra were compiled (220–320nm) using a Varian
Cary3 Spectrophotometer at diﬀerent pH values for cyti-
dine and 5-formylcytidine. The spectra were normalized to
0.2 OD at 260nm. Entire spectra were collected to ensure
that they all intersected at 260nm at an OD of  0.2.
However, the absorbance maximum at 280nm was plotted
against the pH, a previously published method of asses-
sing the pKa of nucleosides (29). A pH range of 2.2–7.0
(citrate-phosphate buﬀer) was used for cytidine, and a pH
range of 1.1–5.0 was used for f
5C (KCl–HCl buﬀer for pH
values between 1.1 and 2.0 and citrate–phosphate buﬀer
for pH values between 2.2 and 5.0). The line ﬁtting and
data analysis was conducted with Prism v3.00 (Graphpad
Software, Inc.) (Figure 7).
RESULTS AND DISCUSSION
A 5-formylcytidine (f
5C) has previously been synthesized
from 5-(hydroxymethyl)cytosine (13) and from 5-methy-
luridine (30), but not incorporated into an RNA sequence.
First, we developed a short (four steps) and facile synthesis
off
5C(compound5,Figure2)fromcommercially available
cytidine (1, Figure 2), starting by protecting cytidine as the
acetonide 2 under standard acid catalysis with an 83%
yield. Installation of the hydroxymethylene unit occurred
through an assisted Baylis-Hillman-type reaction with for-
maldehyde (3, 38% yield, 60% yield based on recovered
starting material; Supplementary Data). Selective oxida-
tion of the allylic alcohol with RuO2 to the aldehyde 4 pro-
ceeded with an 82% yield. The acetonide protecting group
was subsequently removed to deliver f
5C( 5) in 95% yield.
The comparison between the NMR signals of C and those
off
5CclearlydemonstratedthattheC-5positionoff
5Cwas
substituted (Figures 3B and 4C). This substitution was
further conﬁrmed to be the formyl group by the presence
of a low ﬁeld shifted signal at (F1=185p.p.m.;
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Figure 5. Thermal denaturations and circular dichroism spectra of the
hmASL
Met
CAU-27 and the hmASL
Met
CAU-27;f
5C34. (A) Thermodynamic
stability of the ASLs. UV-monitored, thermal data were averaged
from three denaturations and two renaturations for the hmASL
Met
CAU-
27;f
5C34 (thin gray line) and for the hmASL
Met
CAU-27 (thick black line).
(B) Circular dichroism spectra. Spectra of the hmASL
Met
CAU-27;f
5C34
(thin gray line) and that of the hmASL
Met
CAU-27 (thick black line) at
the approximately equal concentrations of 2mM were collected over the
wavelength range of 200 to 300nm.
Nucleic Acids Research, 2008, Vol. 36, No. 20 6553F2=9.40p.p.m.) corresponding to the CH group of the
f
5C modiﬁcation. A complete and unambiguous assign-
ment of the non-exchangeable protons was achieved by
using the two dimensional (2D)
1H-
13C Heteronuclear
Multiple Quantum Correlation (HMQC) method (31,32).
As expected, the NMR peaks observed between
(F1=50.00–85.00p.p.m.; F2=4.50–6.00p.p.m.) corre-
sponded to the protons (H10-H50/H500) of the ribose
moiety (Figure 3B) (33). Conversion of f
5C into the 20,50-
protected f
5C phosphoramidite (9, Figure 2) commenced
with the protection of the 30and 50 hydroxyl groups as a
disiloxane followed by protection of the 4-NH2 group as
the formamidine 6 (71% yield). Installation of a 20-ACE
orthoester [20-O-bis(acetoxyethoxy)methyl-] followed by
ﬂuoride treatment delivered the diol 7 in 53% yield over
two steps (15). The synthesis of the f
5C phosphoramidite
9 was completed through 50-BZH (50-O-benzhydroxy-bis
(trimethylsiloxy)silyl-) protection (8, 84% yield) and
phosphor-amidite formation (93% yield). A major concern
for the incorporation of f
5C phosphoramidite into
synthetic RNA oligomers was the formation of imine
adducts with the formyl group under resin cleavage and
deprotection conditions. However, we decided not to
protect the formyl group since the ﬁnal deprotection of
the 20-ACE groups under mildly acidic conditions
would potentially hydrolyze any imine formation
that results during base-deprotection back to the formyl
group.
In order to investigate the contribution of f
5C34 to the
structure of the anticodon loop and to the decoding
of both the AUG and AUA codons at both the A- and
P-sites, f
5C was incorporated into the anticodon stem and
loop domain of hmtRNA
Met
CAU (hmASL
Met
CAU) at the wobble
position 34, along with pseudouridine, 27. The oligonu-
cleotide was synthesized with 27 and with and without
f
5C34 (hmASL
Met
CAU-27;f
5C34, and hmASL
Met
CAU-27) using
care not to oxidize the formyl group. Incorporation of f
5C
into RNA was accomplished by activating with S-ethyl
tetrazole and coupling of the activated species for
3.5min to the growing polyribonucleotide on the solid-
support. Cleavage from the support and deprotection of
the exocyclic amines was tested using NH4OH at room
temperature for 24h, methylamine at room temperature
for 6h, and t-butyl amine in water (1:3, v/v) at 608C for
6h. Only the t-butyl amine conditions resulted in the cor-
rect mass upon MALDI-TOF analysis of the crude pro-
ducts. There was no indication of any t-butyl-amine
adducts present from the MALDI-TOF results.
Successful incorporation of f
5C was conﬁrmed by NMR
measurements (Figures 3 and 4) and HPLC of constituent
nucleosides (Figure 4). The proton resonance of the
formyl group is observed in the low ﬁeld region of the
1D spectrum of hmASL
Met
CAU-27;f
5C34 and absent from
that of the hmASL
Met
CAU-27 (Figure 3). The formyl
proton in hmASL
Met
CAU-27;f
5C34 resonates at the same
chemical shift as that of the mononucleoside f
5C34,
as observed in the superimposed
1H-
13C HMQC spectra
of cytidine and 5-formylcytidine (Figure 3B). The HPLC
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Figure 7. Analysis of the pKa of (ﬁlled squares) cytidine in comparison
to that of (ﬁlled triangles) 5-formylcytidine. UV spectra were collected
for the two nucleosides over a range of pH values, pH 2.2–7.0 for
cytidine, and a pH 1.1–5.0 for f
5C. The absorbance at 280nm was
normalized and plotted against the pH.
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Figure 6. Codon binding by hmASL
Met
CAU-27 and the hmASL
Met
CAU-27;f
5C34. The equilibrium binding of the two ASLs to the cognate and noncognate
codons, AUG and AUA respectively, was assessed using programmed E. coli ribosomes. (The ASL unmodiﬁed and the wobble position is designated
‘27’; ASL modiﬁed at the wobble position is designated as ‘27;f
5C34’.) The ASLs were bound to the A-site with E. coli ASL
Val3
UAC bound to its
cognate codon in the P-site. The ASLs were bound to the P-site with the ASL
Val3
UAC bound to its cognate codon in the A-site.
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the f
5C (Figure 4A).
The structure of the resulting hmASL
Met
CAU-27;f
5C34 was
characterized by 1D
1H and 2D
1H NOESY NMR experi-
ments conducted in H2Oa t2 8C (34), and by determining
the thermodynamic contributions of f
5C to the RNA. The
formyl proton resonance was found at 9.45p.p.m. corre-
sponding almost exactly to that of the nucleoside alone
(Figure 3A). The imino protons of the stem of
hmASL
Met
CAU-27;f
5C34 were found to resonate between 12
and 13.5p.p.m. on the
1H 1D NMR spectrum (Figure 3A).
The NMR spin systems that involve the exchangeable
imino protons of hmASL
Met
CAU-27;f
5C34 were identiﬁed
by conducting NMR experiments in H2Oa t2 8C
(Figures 3A and Figure 4B). The identiﬁcation and assign-
ment of the exchangeable protons were indicative of the
overall stability the hmASL
Met
CAU-27;f
5C34 in solution, and
the comparison with hmASL
Met
CAU-27 (Figure 3A) demon-
strated the successful incorporation of f
5C34 into the
sequence of hmASL
Met
CAU.
The modiﬁed RNA synthesis has allowed us to begin
examining the role of f
5C34 in thermal stability and decod-
ing activity of hmtRNA
Met. Thermodynamic parameters
were extracted from the repeated denaturations and rena-
turations of both hmASL
Met
CAU-27;f
5C34 and hmASL
Met
CAU-
27 (Table 1 and Figure 5A). Introduction of f
5C34
lowered the melting temperature and standard free
energy (G837) considerably, but did not alter the ASL’s
hyperchromicity. The circular dichroism spectrum of the
hmASL
Met
CAU-27 exhibited a greater ellipticity at 270nm
than that of the hmASL
Met
CAU-27;f
5C34. The lower degree
of ellipticity of hmASL
Met
CAU-27;f
5C34 is indicative of a
decrease in base stacking. The decreased base stacking
must be attributed to the anticodon loop nucleosides
because of the location of the modiﬁcation. These diﬀer-
ences in thermodynamics and circular dichroism ellipticity
between hmASL
Met
CAU-27;f
5C34 and hmASL
Met
CAU-27 indi-
cated that f
5C34 may enhance the motional dynamics of
the loop. This diﬀerence in motional dynamics was
observed by a molecular dynamics simulation (MDS) per-
formed on the hmASL
Met
CAU-27 and the hmASL
Met
CAU-
27;f
5C34 using AMBER 9 (35). The hmASL
Met
CAU-27
displayed an average root mean square deviation from
the starting structure of 2.18 0.23 as opposed to
hmASL
Met
CAU-27;f
5C34 for which higher ﬂuctuations of
2.60 0.60 were detected (Supplementary Data). The
enhanced motional dynamics may be important for the
decoding of AUA, as well as AUG.
The tRNA
Met anticodon CAU is a cognate pair for
the Met codon AUG. According to Crick’s Wobble
Hypothesis (36), the binding of anticodon CAU to
codon AUA would be unlikely due to the C-A mismatch
at the wobble position (wobble pair nucleosides in bold).
However, the mitochondrial ribosome decodes both AUG
and AUA using one tRNA with the anticodon CAU. This
one tRNA consists of the modiﬁcation f
5C34. In contrast,
two tRNAs decode the one Met codon AUG in the cyto-
plasm (37). One of the tRNAs is an initiator tRNA that
decodes AUG in the ribosome’s peptidyl- or P-site at the
initiation of translation, where AUG is the ﬁrst codon to
be translated on the mRNA. This initiator tRNA
Met
CAU con-
sists of an unmodiﬁed CAU anticodon. The second cytopl-
asmic tRNA
Met
CAU is responsible for elongation and
recognizes AUG located within the mRNA, and thus res-
ponds only to the aminoacyl- or A-site codon. In E. coli,
this elongator tRNA
Met is modiﬁed with N4-acetylcytidine
at the wobble position (ac
4C34) (38). Thus, at the antic-
odon, one of the main distinguishing factors between the
cytoplasmic initiator and elongator tRNA
Met
CAU is the mod-
iﬁcation at the wobble position. We used a codon-binding
assay to observe the aﬃnity of the hmASL
Met
CAU-27;f
5C34
and hmASL
Met
CAU-27 for the codons AUA and AUG at
either A-site or P-site of E. coli 70S ribosomes. To ensure
binding of the two ASL
Mets to the A- or the P-site, the
ribosomal site not in observation (P- or A-site, respec-
tively) was saturated with the unmodiﬁed E. coli ASL
Val3
UAC
in response to its cognate codon GUA. The unmodiﬁed
ASL
Val3
UAC binds its cognate codon with high aﬃnity and
speciﬁcity (39).
The hmASL
Met
CAU-27 bound AUG in the A-site and the
P-site with an aﬃnity comparable to what have observed
previously for certain ASLs with unmodiﬁed wobble posi-
tions responding to cognate codons (Figure 6) (21,39). In
contrast, the hmASL
Met
CAU-27 bound poorly to AUA in
both the A- and P-sites. Surprisingly, introduction of
f
5C34 enhanced binding to AUA by 2-fold (Figure 6).
Our results indicated that of the two codons at either of
the two ribosomal sites, the f
5C34 modiﬁcation appears to
be most important for reading AUA.
Both the hmASL
Met
CAU-27 and the fully modiﬁed
hmASL
Met
CAU-27;f
5C34 exhibited considerable aﬃnity for
AUG, and at both the A-site and the P-site. However,
only the hmASL
Met
CAU-27;f
5C34 exhibited signiﬁcant aﬃ-
nity for AUA. There was a doubling in the aﬃnity of
ASL
Met for the AUA codon when f
5C34 was present.
This increase in aﬃnity of the f
5C34-modiﬁed ASL in com-
parison to that of the hmASL
Met
CAU-27, unmodiﬁed at the
wobble position, was not observed on AUG and may
therefore be the sole contributor to the eﬃcient translation
of AUA codons. A 2-fold increase in aﬃnity of tRNA
toward a codon has been shown to be signiﬁcant in trans-
lation (40). Although some ASL modiﬁcations cause small
increases in codon-binding aﬃnity, others can dramati-
cally increase aﬃnity to codons (39).
Table 1. Thermodynamic contributions of f
5C34
hmASL
Met
CAU Tm (8C) G
 
37 (kcal/mol) H (kcal/mol) S (cal/K mol) Hyperchromicity (%)
27 67.7 1.8 –2.8 0.1 –31.1 2.0 –91.3 6.3 16 1
27;f
5C34 60.1 0.8 –1.6 0.1 –22.8 1.2 –68.4 3.4 16 1
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tional mechanisms by which a stable, but noncanonical
base pair occurs between f
5C34 and the third base of the
AUA codon, an adenosine, on the ribosome. C-A base
pairs are extremely unusual. Although the C-A pairing
has been found in the folded structure of some RNAs
such as ribosomal RNAs (rRNAs), it is rarely found in
anticodon:codon pairs. An anticodon:codon C-A mis-
match has been detected when C34 of tRNA
Ile
CAU, mod-
iﬁed with lysidine (k
2C34) at the wobble position, is paired
to the cytoplasmic isoleucine codon AUA. The lysine
moiety of C34 on the anticodon provides an amino
group which hydrogen bonds to A of the codon, thus
allowing the wobble position C-A mismatch to occur.
One could imagine that the 5-formyl modiﬁcation raises
the pKa of cytidine’s N3 to the physiological range where
an additional hydrogen bond could be formed to AUA.
However, the pKa of f
5C determined by UV spectral anal-
ysis was lower than that of C (2.3 and 4.2, respectively;
Figure 7), corresponding well with previous determina-
tions (41) including those for df
5C (42) and for f
5U (43).
Thus, f
5C must contribute to the decoding of the mito-
chondrial genome through a diﬀerent mechanism.
Another C-A anticodon:codon mismatch may occur at
the wobble position when tRNA
Leu
f CmAA pairs with the leu-
cine codon UUA. Similar to hmtRNA
Met, this tRNA
Leu
isoacceptor has a 5-formylated, 20-O-methylated C at the
wobble position, f
5Cm34. The wobble modiﬁcations are
thought to be a general characteristic of mammalian cyto-
plasmic tRNA
Leu that may aid in the decoding of leucine
codons UUG and UUA and prevent the miscoding of the
similar codons of phenylalanine, UUU and UUC.
However, there is a lack of information on the decoding
properties of tRNA
Leu
f5CmAA and therefore, there is the pos-
sibility that an isoacceptor other than tRNA
Leu
f5CmAA is
responsible for speciﬁcally reading UUA (6,38).
Eighty percent of the methionine codons internal to
mitochondrial mRNA are the AUA codon. Thus, the
enhanced aﬃnity of hmASL
Met
CAU-27;f
5C34 for AUA in
the A-site of the E. coli ribosome has important implica-
tions for the aﬃnity and kinetics of decoding AUA during
elongation. The enhanced A-site binding of AUA by the
f
5C-modiﬁed, hmASL
Met
CAU may be even more evident on
the mitochondrial ribosome, a concept not studied here.
Also, the disease-related A37-G37 (A4435G) mutation,
associated with an increased penetrance and expression
of the primary Leber hereditary optic neuropathy muta-
tion (G11778A), LHON (44), may critically alter the
anticodon architecture such that either or both decoding
events do not occur. This has yet to be examined. The
synthesis of the wild-type modiﬁed and unmodiﬁed antic-
odon stem and loops of the hmASL
Met
CAU and their physical,
chemical characterizations will be important in under-
standing the contributions of the modiﬁcation to
biological function and in characterization of the human
disease-relevant mutant tRNA.
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